These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3817870)

  • 1. Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge.
    Dunn PL; Johnson CA; Styles JM; Pease SS; Dean CJ
    Immunology; 1987 Feb; 60(2):181-6. PubMed ID: 3817870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of syngeneic rat monoclonal antibodies to the HSN tumor using syngeneic monoclonal anti-idiotopic antibodies.
    Léger O; Dean CJ
    J Immunol; 1991 Apr; 146(8):2879-86. PubMed ID: 1901889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-idiotypic antibodies: powerful tools in diagnosis and therapy.
    Walter G; Friesen HJ; Harthus HP
    Behring Inst Mitt; 1988 Apr; (82):182-92. PubMed ID: 3044338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
    North SM; Styles JM; Hobbs SM; Dean CJ
    Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immunity to rat sarcomata induced by syngeneic monoclonal anti-idiotype antibody.
    Dunn PL; Johnson CA; Styles JM; Dean CJ
    Monogr Allergy; 1987; 22():222-4. PubMed ID: 3501836
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies to rat sarcomata. II. A syngeneic IgG2b antibody with anti-tumour activity.
    North SM; Dean CJ
    Immunology; 1983 Aug; 49(4):667-71. PubMed ID: 6874004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of anti-antiidiotypic IgE antibodies obtained from an IgE monoclonal antibody specific for a 26-kilodalton Schistosoma mansoni antigen.
    Velge-Roussel F; Verwaerde C; Grzych JM; Auriault A; Capron A
    J Immunol; 1989 Apr; 142(7):2527-32. PubMed ID: 2494262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
    Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
    Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody.
    Chakraborty M; Mukerjee S; Foon KA; Köhler H; Ceriani RL; Bhattacharya-Chatterjee M
    Cancer Res; 1995 Apr; 55(7):1525-30. PubMed ID: 7533665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
    Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
    J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of monoclonal antibodies utilizing the host anti-idiotypic network.
    Hatzistilianou MN; Sivolapenko GB; Courtenay-Luck NS; Epenetos AA; Ritter MA
    In Vivo; 1995; 9(2):139-44. PubMed ID: 7548789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotypic analysis of anti-I-Ak monoclonal antibodies. I. Production and characterization of syngeneic anti-idiotypic mAb against an anti-I-Ak mAb.
    Phillips ML; Harris JF; Delovitch TL
    J Immunol; 1984 Nov; 133(5):2587-94. PubMed ID: 6434633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gangliosides, Ab1 and Ab2 antibodies III. The idiotype of anti-ganglioside mAb P3 is immunogenic in a T cell-dependent manner.
    López-Requena A; Bestagno M; Mateo de Acosta C; Cesco-Gaspere M; Vázquez AM; Pérez R; Burrone OR
    Mol Immunol; 2007 Apr; 44(11):2915-22. PubMed ID: 17316805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of an anti-idiotype monoclonal antibody related to GM3(NeuGc) ganglioside.
    Rodríguez M; Llanes L; Pérez A; Pérez R; Vázquez AM
    Hybrid Hybridomics; 2003 Oct; 22(5):307-14. PubMed ID: 14678648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immuno-therapeutic study of anti-idiotype minibody (single chain Fv-CH3) on ovarian carcinoma bearing mice].
    Li Y; Chang XH; Cui H; Yang WL; Feng J; Wei LH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):451-6. PubMed ID: 12974094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to the idiotypic determinants of a human IgG paraprotein: evidence for complexity of the anti-idiotype response.
    Ling NR; Lowe J; Jefferis R
    Clin Exp Immunol; 1982 Apr; 48(1):1-7. PubMed ID: 6177459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
    Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
    Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.